Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00888732Phase 3Completed
A Phase 3 trial of insulin aspart, Insulin aspart + insulin aspart protamine, human insulin in type 1 diabetes mellitus (T1D), sponsored by Aarhus University. Started Jun 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00888732.